Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Usha Bughani"'
Autor:
Chaitali Dey, Srinivas Reddy Boreddy, Reshmi Nair, Arindam Banerjee, Anshu Kuriakose, Prashant Kumar Pandey, Meena Shri, Shruthi Rao, Bhadravathi Marigowda Shivakumar, Moni Abhram Kuriakose, Ram Bhupal Reddy, Amritha Suresh, Praveen Reddy Moole, Usha Bughani, Seng-Lai Tan, Pradip Nair
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/a5b9658199994971890ba735fb92fb51
Autor:
Usha Bughani, Arindam Saha, Anshu Kuriakose, Reshmi Nair, Ravindra B Sadashivarao, Rasika Venkataraman, Swati Patel, Anuja Tushar Deshchougule, Kumar S Satish, Enrique Montero, Harish V Pai, Dinesh V Palanivelu, Ramakrishnan Melarkode, Pradip Nair
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0192335 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0180088.].
Externí odkaz:
https://doaj.org/article/1c22fa488f94401a8e39af0a7fad63fe
Autor:
Usha Bughani, Arindam Saha, Anshu Kuriakose, Reshmi Nair, Ravindra B Sadashivarao, Rasika Venkataraman, Swati Patel, Anuja Tushar Deshchougule, Satish Kumar S, Enrique Montero, Harish V Pai, Dinesh V Palanivelu, Ramakrishnan Melarkode, Pradip Nair
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production
Externí odkaz:
https://doaj.org/article/c65b7916659142f78e52a699d7aa8db6
Autor:
Srinivas Reddy Boreddy, Reshmi Nair, Prashant Kumar Pandey, Anshu Kuriakose, Shivakumar Bhadravathi Marigowda, Chaitali Dey, Arindam Banerjee, Hanumant Kulkarni, Milind Sagar, Shiv Ram Krishn, Shruthi Rao, Madhukara AR, Vinita Tiwari, Bhavna Alke, Prashantha Kumar MV, Meena Shri, Chaitrali Dhamne, Sonal Patel, Pinky Sharma, Sankar Periyasamy, Jaya Bhatnagar, Moni Abraham Kuriakose, Ram Bhupal Reddy, Amritha Suresh, Suma Sreenivas, Nagaraja Govindappa, Praveen Reddy Moole, Usha Bughani, Seng-Lai Tan, Pradip Nair
Publikováno v:
Cancer Research. :OF1-OF22
The EGFR and TGFβ signaling pathways are important mediators of tumorigenesis, and cross-talk between them contributes to cancer progression and drug resistance. Therapies capable of simultaneously targeting EGFR and TGFβ could help improve patient
Autor:
Pradip Nair, Seng-Lai Tan, Usha Bughani, Praveen Reddy Moole, Nagaraja Govindappa, Suma Sreenivas, Amritha Suresh, Ram Bhupal Reddy, Moni Abraham Kuriakose, Jaya Bhatnagar, Sankar Periyasamy, Pinky Sharma, Sonal Patel, Chaitrali Dhamne, Meena Shri, Prashantha Kumar MV, Bhavna Alke, Vinita Tiwari, Madhukara AR, Shruthi Rao, Shiv Ram Krishn, Milind Sagar, Hanumant Kulkarni, Arindam Banerjee, Chaitali Dey, Shivakumar Bhadravathi Marigowda, Anshu Kuriakose, Prashant Kumar Pandey, Reshmi Nair, Srinivas Reddy Boreddy
Supplementary data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e16c3026aa720d6f43efd523a2c59a
https://doi.org/10.1158/0008-5472.22929363
https://doi.org/10.1158/0008-5472.22929363
Autor:
Pradip Nair, Seng-Lai Tan, Usha Bughani, Praveen Reddy Moole, Nagaraja Govindappa, Suma Sreenivas, Amritha Suresh, Ram Bhupal Reddy, Moni Abraham Kuriakose, Jaya Bhatnagar, Sankar Periyasamy, Pinky Sharma, Sonal Patel, Chaitrali Dhamne, Meena Shri, Prashantha Kumar MV, Bhavna Alke, Vinita Tiwari, Madhukara AR, Shruthi Rao, Shiv Ram Krishn, Milind Sagar, Hanumant Kulkarni, Arindam Banerjee, Chaitali Dey, Shivakumar Bhadravathi Marigowda, Anshu Kuriakose, Prashant Kumar Pandey, Reshmi Nair, Srinivas Reddy Boreddy
The EGFR and TGFβ signaling pathways are important mediators of tumorigenesis, and cross-talk between them contributes to cancer progression and drug resistance. Therapies capable of simultaneously targeting EGFR and TGFβ could help improve patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3b64f8b973e7dd30b6b4eeaaf1837f
https://doi.org/10.1158/0008-5472.c.6653403.v1
https://doi.org/10.1158/0008-5472.c.6653403.v1
Autor:
Pradip Nair, Amritha Suresh, Moni Abhram Kuriakose, Chaitali Dey, Srinivas Reddy Boreddy, Praveen Reddy Moole, Arindam Banerjee, Usha Bughani, Seng-Lai Tan, Reshmi Nair, Bhadravathi Marigowda Shivakumar, Anshu Kuriakose, Meena Shri, Shruthi Rao, Ram Bhupal Reddy, Prashant Kumar Pandey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundGiven the pleiotropic functions of transforming growth factor-beta (TGFβ), current approaches to targeting systemic TGFβ will likely lead to suboptimal clinical activity and/or undesirable effects. Epidermal growth factor receptor (EGFR)
Autor:
Arindam Saha, S Satish Kumar, Pradip Nair, Swati Patel, Ravindra B. Sadashivarao, Anuja Tushar Deshchougule, H. Pai, Ramakrishnan Melarkode, Usha Bughani, Dinesh V. Palanivelu, Reshmi Nair, Enrique Montero, Rasika Venkataraman, Anshu Kuriakose
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production
Autor:
Agnieszka Bialkowska, Amr M. Ghaleb, Usha Bughani, Shiwang Li, Jing He, Harish C. Joshi, Vincent W. Yang
Publikováno v:
International Journal of Cancer. 131:1435-1444
Germline mutation of the tumor suppressor gene, adenomatous polyposis coli (APC), is responsible for familial adenomatous polyposis (FAP) with nearly 100% risk for colon cancer at an early age. Although FAP is involved in only 1% of all colon cancer
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab
Autor:
Pradip Nair, H. Pai, Ravindra B. Sadashivarao, Swati Patel, Anuja Tushar Deshchougule, Reshmi Nair, Arindam Saha, Kumar Satish, Enrique Montero, Dinesh V. Palanivelu, Ramakrishnan Melarkode, Anshu Kuriakose, Usha Bughani, Rasika Venkataraman
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0192335 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0180088.].